The Louisiana Academy of Family Physicians cordially invites you to attend a CME presentation titled\, “Evaluating the Role and Impact of Primary Care Providers on the Treatment of Patients Wit h Moderate-to-Severe Asthma.” \; \;This activity is s upported by an independent educational grant from Regeneron Pharmaceutical s\, Inc and Sanofi.

Learning Objectives

\;Define high intensity treatment in patients with a sthma.
\;Utilize clinical indicators to assess or refer pat ients for escalation of asthma therapy including add-on biologics.
\;Apply recommendation for biomarker t esting in evaluation of patients with asthma.
\;Implement s trategies for effective management of patients with asthma with biologic t herapies in collaboration with asthma specialists.

Registration

Attendance is free\, but registrati on is required. \; \;

Register Today!< /p>\n

Program Faculty

Nic ola (Nick) A. Hanania\, MD\, MS

Dr. Hanania is Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and dir ector of the Airways Clinical Research Center at the Baylor College of Med icine in Houston\, Texas. He also serves on the Executive Faculty Senate a s the Clinical Science Representative at Baylor College of Medicine. He is the Chief of Section of Pulmonary\, Critical Care and Sleep Medicine at B en Taub Hospital. He completed his medical training at the University of J ordan in Amman\, Jordan\, followed by a residency in internal medicine and a fellowship in pulmonary medicine at the University of Toronto\, Toronto \, Canada. He subsequently completed a fellowship in critical care medicin e at Baylor College of Medicine\, where he later earned a master’s degree in clinical investigation.

Dr Hanania is fellow of the Royal Colle ge of Physicians and Surgeons of Canada\, American College of Physicians\, American College of Chest Physicians\, European Respiratory Society and A merican Thoracic Society. He has received multiple awards\, including the ACCP’s Distinguished Scholar in Respiratory Health\, Baylor College of Med icine Master Clinician Award\, ACCP distinguished CHEST educator (DCE)\, A CCP Humanitarian Award\, Fulbright and Jaworski’s Faculty Excellence Award for Teaching and Evaluation\, and the Award for Excellence in Teaching fr om the Department of Medicine at Baylor College of Medicine. He is editor- in-chief of Respiratory Medicine and is associate editor of the journal Lu ng. He serves on the editorial board of Chest\, and COPD (J of COPD Founda tion). Dr Hanania’s research interests focus on the pharmacology and manag ement of asthma and COPD. He has published more than 320 peer-reviewed pap ers\, book chapters\, editorials\, and reviews on these topics. His resear ch has been funded by NIH\, ALA and industry and focuses on clinical trial s investigating novel treatments. He is principal investigator for the Ame rican Lung Association Airways Clinical Research Center and COPD Gene stud y at Baylor College of Medicine\, as well as principal investigator or co- investigator in several clinical trials in asthma and COPD. Dr Hanania has been invited and has lectured widely at local\, regional\, national\, and international meetings.

CME Accreditation

The AAFP has reviewed 2026 Monthly Webinar/Gra nd Rounds Series and deemed it acceptable for AAFP credit. Terms of approv al is from 1/20/2026 to 12/23/2026. Physicians should claim only the credi t commensurate with the extent of their participation in the activity. Cre dit approval is for 1.00 In-Person\, Live (could include online) AAFP Pres cribed Credit(s) and includes the following session(s): -“Evaluat ing the Role and Impact of Primary Care Providers on the Treatment of Pati ents With Moderate-to-Severe Asthma.”

Questions

\n
\n
For questions regarding CME credit or the evaluation\, please email \;This ema il address is being protected from spambots. You need JavaScript enabled t o view it..
\n

\n
The Louisiana Academy of Family Phys icians cordially invites you to attend a CME presentation titled\, “Evaluating the Role and Impact of Primary Care Providers on the Treatmen t of Patients With Moderate-to-Severe Asthma.” \; \;T his activity is supported by an independent educational grant from Regener on Pharmaceuticals\, Inc and Sanofi.
\n
Learning Object ives
\n
\n
\;Define high intensity treatment i n patients with asthma.
\n
\;Utilize clinical indicators to as sess or refer patients for escalation of asthma therapy including add-on b iologics.
\n
\;Analyze efficacy and safety data of available b iologics for the treatment of asthma.
\n
\;Apply recommendatio n for biomarker testing in evaluation of patients with asthma.
\n
& nbsp\;Implement strategies for effective management of patients with asthm a with biologic therapies in collaboration with asthma specialists.
\n
\n
Registration
\n
\n
Attendance is free \, but registration is required. \; \;
\n
Register Tod ay!
\n
Program Faculty
\n
\n
Nicola (Nick) A. Hanania\, MD\, MS
\n
Dr. Hana nia is Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and director of the Airways Clinical Research Center at the Bayl or College of Medicine in Houston\, Texas. He also serves on the Executive Faculty Senate as the Clinical Science Representative at Baylor College o f Medicine. He is the Chief of Section of Pulmonary\, Critical Care and Sl eep Medicine at Ben Taub Hospital. He completed his medical training at th e University of Jordan in Amman\, Jordan\, followed by a residency in inte rnal medicine and a fellowship in pulmonary medicine at the University of Toronto\, Toronto\, Canada. He subsequently completed a fellowship in crit ical care medicine at Baylor College of Medicine\, where he later earned a master’s degree in clinical investigation.
\n
Dr Hanania is fellow o f the Royal College of Physicians and Surgeons of Canada\, American Colleg e of Physicians\, American College of Chest Physicians\, European Respirat ory Society and American Thoracic Society. He has received multiple awards \, including the ACCP’s Distinguished Scholar in Respiratory Health\, Bayl or College of Medicine Master Clinician Award\, ACCP distinguished CHEST e ducator (DCE)\, ACCP Humanitarian Award\, Fulbright and Jaworski’s Faculty Excellence Award for Teaching and Evaluation\, and the Award for Excellen ce in Teaching from the Department of Medicine at Baylor College of Medici ne. He is editor-in-chief of Respiratory Medicine and is associate editor of the journal Lung. He serves on the editorial board of Chest\, and COPD (J of COPD Foundation). Dr Hanania’s research interests focus on the pharm acology and management of asthma and COPD. He has published more than 320 peer-reviewed papers\, book chapters\, editorials\, and reviews on these t opics. His research has been funded by NIH\, ALA and industry and focuses on clinical trials investigating novel treatments. He is principal investi gator for the American Lung Association Airways Clinical Research Center a nd COPD Gene study at Baylor College of Medicine\, as well as principal in vestigator or co-investigator in several clinical trials in asthma and COP D. Dr Hanania has been invited and has lectured widely at local\, regional \, national\, and international meetings.
\n

\n
CME Accr editation
\n
\n

\n
The AAFP has reviewed 2026 Mo nthly Webinar/Grand Rounds Series and deemed it acceptable for AAFP credit . Terms of approval is from 1/20/2026 to 12/23/2026. Physicians should cla im only the credit commensurate with the extent of their participation in the activity. Credit approval is for 1.00 In-Person\, Live (could include online) AAFP Prescribed Credit(s) and includes the following session(s): - “Evaluating the Role and Impact of Primary Care Providers on the Treatment of Patients With Moderate-to-Severe Asthma.”
\n

Questions

For questions regarding CME credit or the evaluation\, please email \;This email address is being protected from spambots. You need Jav aScript enabled to view it..

\n END:VEVENT END:VCALENDAR